The ghrelin axis in disease: potential therapeutic indications.

Abstract

Ghrelin, the natural ligand for the growth hormone (GH)-secretagogue receptor (GHS-R), is produced predominantly in the stomach. It is present in the circulation in two major forms, an acylated and an unacylated form, both of which have reported activities. Some of the best understood actions of acylated ghrelin administration are its orexigenic effects, and the stimulation of GH secretion. Ghrelin also seems to play a role in glucose homeostasis, lipid metabolism and immune function. Based on its orexigenic and metabolic effects, ghrelin and ghrelin mimetics have potential benefit in antagonizing protein breakdown and weight loss in catabolic conditions such as cancer cachexia, renal, cardiac and pulmonary disease, and age-related frailty. Ghrelin also has potentially useful positive effects on cardiac function and gastric motility. Ghrelin antagonists may be of benefit to increase insulin sensitivity and potentiate weight loss. The following chapter presents some background on ghrelin and ghrelin assays and discusses some of the potential therapeutic approaches for the use of ghrelin, ghrelin mimetic compounds and ghrelin antagonists in clinical disease.

• Authors: Ralf Nass, Bruce D Gaylinn, Michael O Thorner
• Journal: Molecular and cellular endocrinology (Mol Cell Endocrinol) Vol. 340 Issue 1 Pg. 106-10 (Jun 20 2011) ISSN: 1872-8057 [Electronic] Ireland
• PMID: 21356273 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Chemical References

• Ghrelin

Topics

• Animals
• Biological Assay
• Disease
• Ghrelin (administration & dosage, antagonists & inhibitors, therapeutic use)
• Humans